The effects of gabapentin and memantine in acquired and congenital nystagmus: A retrospective study

British Journal of Ophthalmology

Volumn 90, Issue 7, 2006, Pages 839-843

  Shery, T ^a   Proudlock, F A ^a   Sarvananthan, N ^a   McLean, R J ^a   Gottlob, Irene ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; MEMANTINE;

ADULT; AGED; AMNESIA; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONGENITAL NYSTAGMUS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EYE DISEASE; EYE FIXATION; EYE MOVEMENT; FATIGUE; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARESTHESIA; PRIORITY JOURNAL; RANK SUM TEST; SKIN TINGLING; VISION; VISION TEST; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AMINES; CYCLOHEXANECARBOXYLIC ACIDS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MEMANTINE; MIDDLE AGED; MULTIPLE SCLEROSIS; NYSTAGMUS, CONGENITAL; NYSTAGMUS, PATHOLOGIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISION TESTS;

EID: 33745650082     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.086322     Document Type: Article

References (16)

1. Pilling RF, Thomspon JR, Gottlob I. Social and visual Function in nystagmus. Br J Ophthalmol 2005;89:1278-81.
2. Straube A. Differential effects of bicuculline and muscimol microinjections into the vestibular nuclei on simian eye movements. Exp Brain Res 1991;86:347-58.
3. Mettens P. Effect of muscimol microinjections into the prepositus hypoglossi and the medial vestibular nuclei on cat eye movements. J Neurophysiol 1994;72:785-802.
4. Arnold DB. Nystagmus induced by pharmacological inactivation of the brainstem ocular motor integrator in monkeys. Vis Res 1999;39:4286-95.
5. Averbuch-Heller L. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997;41:818-25.
6. Stark M. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 1997;244:9-16.
7. Schon F. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology 1999;53:2209-10.
8. Averbuch-Heller L. Eye movements. Curr Opin Neurol 1996;1196:26-31.
9. Strupp M, Schüller O, Krafczyk S, et al. Treatment of downbeat nystgamus with 3,4 diaminopyridine. A placebo controlled study. Neurology 2003;61:165-70.
10. Hertle RW, Maybodi M, Mellow SD, et al. Clinical and oculographic response to Tenuate Dospan (diethylpropionate) in a patient with congenital nystagmus. Am J Ophthalmol 2002;133:159-60.
11. Hertle RW, Maybodi M, Bauer RM, et al. Clinical and oculographic response to Dexedrine in a patient with rod-cone dystrophy, exotropia, and congenital aperiodic alternating nystagmus. Binocul Vis Strabismus Q 2001;16:259-64.
12. Sarvananthan N, Gottlob I. Pharmacological treatment of congenital nystagmus. Arch Ophthalmol, (in press).
13. Jain S, Proudlock FA, Constantinescu CS, et al. Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol 2002;134:780-2.
14. White SH. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 1999;40(suppl 5):S2-S10.
15. Bandini F, Castello E, Mazzella L, et al. Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry 2001;71:107-10.
16. Stahl JS, Rottach KG, Averbuch-Heller L. A pilot study of gabapentin as treatment for acquired nystagmus. Neuro-ophthalmology 1996;16:107-13.